UAB "Lotos pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,986,806 |
| 225,517 |
| 281,967 |
| 232,782 |
| 26,422 |
| 43.42 |
| 11.72 |
| 1,095,992 |
| 594,082 |
| 18,664 |
| 1,667,765 |
| 0.54 |
| 0.54 |
| - |
| - |
| 14.24 |
| 282,884 |
| 2024 |
|---|
| 1,665,695 |
| 200,445 |
| -85,888 |
| -85,888 |
| -10,335 |
| 39.81 |
| -5.16 |
| 939,516 |
| 1,096,952 |
| 50,816 |
| 1,991,331 |
| 0.55 |
| 1.17 |
| - |
| - |
| -5.04 |
| -83,892 |
| 2025 |
|---|
| 1,826,442 |
| 217,434 |
| -217,591 |
| -217,591 |
| -25,904 |
| 40.85 |
| -11.91 |
| 721,925 |
| 1,126,415 |
| 35,928 |
| 1,806,815 |
| 0.39 |
| 1.56 |
| - |
| - |
| -11.73 |
| -214,256 |
| 2025 |
|---|
| 1,826,442 |
| 217,434 |
| -217,591 |
| -217,591 |
| -25,904 |
| 40.85 |
| -11.91 |
| 721,925 |
| 1,126,415 |
| 35,928 |
| 1,806,815 |
| 0.39 |
| 1.56 |
| - |
| - |
| -11.73 |
| -214,256 |
Turnover (€)
2025
Turnover (€)
1,826,442 €10 % *
Sales per employee (€)
217,434 €8 % *
Profit before tax (€)
-217,591 €-153 % *
Net Profit (€)
-217,591 €-153 % *
Profit per employee (€)
-25,904 €-151 % *
Total profitability (%)
40.85 %2.61 % *
Net profitability (%)
-11.91 %-130.81 % *
Equity (€)
721,925 €-23 % *
Amounts Payable And Liabilities (€)
1,126,415 €3 % *
Non-current Assets (€)
35,928 €-29 % *
CurrentAssets (€)
1,806,815 €-9 % *
Working capital requirement
0.39 -29.09 % *
Debt-to-equity ratio
1.56 33.33 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-11.73 %-132.74 % *
EBIT (€)
-214,256 €-155 % *
